Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study
替雷利珠单抗对比化疗作为晚期或转移性食管鳞状细胞癌二线治疗(RATIONALE-302):一项随机III期研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01926
Shen, Lin; Kato, Ken; Kim, Sung-Bae; Ajani, Jaffer A; Zhao, Kuaile; He, Zhiyong; Yu, Xinmin; Shu, Yongqian; Luo, Qi; Wang, Jufeng; Chen, Zhendong; Niu, Zuoxing; Zhang, Longzhen; Yi, Tienan; Sun, Jong-Mu; Chen, Jianhua; Yu, Guohua; Lin, Chen-Yuan; Hara, Hiroki; Bi, Qing; Satoh, Taroh; Pazo-Cid, Roberto; Arkenau, Hendrick-Tobias; Borg, Christophe; Lordick, Florian; Li, Liyun; Ding, Ningning; Tao, Aiyang; Shi, Jingwen; Van Cutsem, Eric